Abstract
In situ replacement of infected vascular grafts is an accepted alternative to total graft excision and extraanatomic replacement. Its success relies upon the ability of the newly inserted graft to resist recurrent infection. This study compares the efficacy of two methods used to reduce the risk of graft reinfection: rifampicin soaking versus silver bonding of grafts. The grafts’ resistance to infection was tested in vitro in two protocols, each using a panel of seven common bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). The length of time the grafts remained free of organisms was compared between the groups. Both the silver graft and the rifampicin-soaked graft were significantly better than control graft at preventing bacterial growth on the graft surface. The rifampicin inhibited the growth of the gram-positive organisms, including MRSA, significantly better than the silver graft on days 2 and 3 (p < 0.001). Conversely, the silver graft was significantly more effective against the gram-negative organisms until day 4 (p < 0.0001). Both types of graft inhibit the in vitro growth of bacteria more effectively than controls, with rifampicin being most effective against gram-positive organisms and silver being best against the gram-negative organisms.
Similar content being viewed by others
References
PD Hayes A Nasim NJL London et al. (1999) ArticleTitleRifampicin bonded grafts for the treatment of major aortic graft infection: the Leicester experience J. Vasc. Surg. 30 92–98 Occurrence Handle1:STN:280:DyaK1MzisVSkug%3D%3D Occurrence Handle10394158
AR Naylor PD Hayes S Darke (2001) ArticleTitleA prospective audit of complex wound and graft infections in Great Britain and Ireland: the emergence of MRSA Eur. J. Vasc. Endovasc. Surg. 21 289–294 Occurrence Handle10.1053/ejvs.2001.1311 Occurrence Handle1:STN:280:DC%2BD3M3nsFymtA%3D%3D Occurrence Handle11359327
A Chervu W Moore M Chvapil et al. (1991) ArticleTitleEfficacy and duration of anti-staphylococcal activity comparing 3 antibiotics bonded to Dacron vascular grafts with a collagen release system J. Vasc. Surg. 13 897–901 Occurrence Handle10.1067/mva.1991.27349 Occurrence Handle1:STN:280:By6B2crmsVc%3D Occurrence Handle1828092
PE Magnan P Seyral D Raoult et al. (1994) ArticleTitleIn vitro anti-staphylococcal activity of collagen-sealed Dacron vascular prosthesis bonded with rifampicin, vancomycin or amikacin Ann. Vasc. Surg. 8 243–247 Occurrence Handle1:STN:280:ByuA3MfjvVU%3D Occurrence Handle8043357
CJL Strachan SWB Newsome TR Ashton (991) ArticleTitleThe clinical use of an antibiotic-bonded graft Eur. J. Vasc. Surg. 5 627–632
Mertens, RA, O’Hara, PJ, Hertzer, NR, et al. (1995) “Surgical management of infra-inguinal arterial prosthetic graft infections: review of a thirty-five year experience” J. Vasc. Surg. 21: 782–790
Lorentzen, JE, Nielsen, OM, Arendrup, H, et al. (1985) “Vascualr graft infection: an analysis of sixty-two graft infections in 2411 consecutively implanted synthetic vascular grafts” Surgery 98: 81–86
Edwards, WH, Jr, Martin, RS, III, Jenkins, JM, et al. (1987) “Primary graft infections” J. Vasc. Surg. 6: 235–239
Calligaro, KD, Veith, FJ, Schwartz, ML, et al. (1995) “Recommendations for initial antibiotic treatment of extracavitary arterial graft infections” Am. J. Surg. 170: 123–125
DC Speller AP Johnson D James et al. (1997) ArticleTitleResistance to methicillin and other antibiotics in isolates of S. aureus from blood and CSF, England and Wales, 1989-1995 Lancet 350 323–325 Occurrence Handle10.1016/S0140-6736(97)12148-1 Occurrence Handle1:CAS:528:DyaK2sXls1emur4%3D Occurrence Handle9251636
DF Bandyk ML Novotney BL Johnson et al. (2001) ArticleTitleUse of rifampicin-soaked gelatin-sealed polyester grafts for in situ treatment of primary aortic and vascular prosthetic infections J. Surg. Res. 95 44–49 Occurrence Handle10.1006/jsre.2000.6035 Occurrence Handle1:CAS:528:DC%2BD3cXovVOgtLs%3D Occurrence Handle11120634
G Torsello W Sandman (1997) ArticleTitleUse of antibiotic-bonded grafts in vascular graft infection Eur. J. Vasc. Endovasc. Surg. 14 IssueIDSuppl A 84–87 Occurrence Handle1:STN:280:ByiH28%2Fks1I%3D
M D’Addato T Curti A Freyrie (1996) ArticleTitleProphylaxis of graft infection with rifampicin-bonded Gelseal graft: two-year follow-up of a prospective clinical trial Cardiovasc. Surg. 4 200–204 Occurrence Handle10.1016/0967-2109(96)82315-5 Occurrence Handle1:STN:280:ByiD3MvmtVA%3D Occurrence Handle8861437
BD Braithwaite B Davies BP Heather et al. (1998) ArticleTitleEarly results of a randomized trial of rifampicin-bonded Dacron grafts for extra-anatomic vascular reconstruction. Joint Vascular Research Group Br. J. Surg. 85 1378–1381 Occurrence Handle10.1046/j.1365-2168.1998.00878.x Occurrence Handle1:STN:280:DyaK1cvltlakuw%3D%3D Occurrence Handle9782018
RO Darouiche (1999) ArticleTitleAnti-infective efficacy of silver-coated medical prostheses Clin. Infect. Dis. 29 1371–1377 Occurrence Handle10.1086/313561 Occurrence Handle1:STN:280:DC%2BD3c%2Fltl2itA%3D%3D Occurrence Handle10585781
JM Schierholz LJ Lucas A Rump G Pulverer (1998) ArticleTitleEfficacy of silver-coated medical devices J. Hosp. Infect. 40 257–262 Occurrence Handle1:STN:280:DyaK1M%2FosFGjtQ%3D%3D Occurrence Handle9868616
SL Mc Hugh RC Merellering CC Hopkins et al. (1975) ArticleTitle Salmonella typhimurium resistant to silver nitrate, chloramphenicol and ampicillin Lancet 1 235–240 Occurrence Handle1:STN:280:CSqD1MbhvFc%3D Occurrence Handle46385
AT Hendry IO Stewart (1979) ArticleTitleSilver-resistant Enterobacteriacae from hospital patients Can. J. Microbiol. 25 915–921 Occurrence Handle1:CAS:528:DyaE1MXltlCktLo%3D Occurrence Handle526888
E Kinney D Bandyk G Seabrook et al. (1991) ArticleTitleAntibiotic-bonded PTFE vascular grafts: the effect of silver antibiotic on bioactivity following implantation J. Surg. Res. 50 430–435 Occurrence Handle1:CAS:528:DyaK3MXksFOitr8%3D Occurrence Handle2038181
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Hardman, S., Cope, A., Swann, A. et al. An In Vitro Model to Compare the Antimicrobial Activity of Silver-Coated Versus Rifampicin-Soaked Vascular Grafts. Ann Vasc Surg 18, 308–313 (2004). https://doi.org/10.1007/s10016-004-0042-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10016-004-0042-5